HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism.

Abstract
The γ-aminobutyric acid (GABA) system plays a pivotal role in orchestrating the synchronicity of local networks and the functional coupling of different brain regions. Here we review the impact of the GABAA receptor subtypes on cognitive and emotional behavior, paying particular attention to five disease states: cognitive dysfunction and Down syndrome, anxiety disorders, depression, schizophrenia, and autism. Through the bidirectional modulation of tonic inhibition, α5-subunit-containing GABAA receptors permit the bidirectional modulation of cognitive processes, and a partial inverse agonist acting at the α5-subunit-containing GABAA receptor is in a clinical trial in individuals with Down syndrome. With regard to anxiety disorders, the viability of nonsedative anxiolytics based on the modulation of α2- and α3-subunit-containing GABAA receptors has been established in clinical proof-of-concept trials. Regarding the remaining three disease states, the GABA hypothesis of depression offers new options for antidepressant drug development; cognitive symptoms in schizophrenia are attributed to a cortical GABAergic deficit, and dysfunctional GABAergic inhibition is increasingly understood to contribute to the pathophysiology of autism spectrum disorders.
AuthorsUwe Rudolph, Hanns Möhler
JournalAnnual review of pharmacology and toxicology (Annu Rev Pharmacol Toxicol) Vol. 54 Pg. 483-507 ( 2014) ISSN: 1545-4304 [Electronic] United States
PMID24160694 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Receptors, GABA-A
Topics
  • Animals
  • Autistic Disorder (therapy)
  • Brain (metabolism)
  • Clinical Trials as Topic
  • Cognition (physiology)
  • Disease Models, Animal
  • Down Syndrome (therapy)
  • Humans
  • Memory (physiology)
  • Molecular Targeted Therapy
  • Mood Disorders (therapy)
  • Receptors, GABA-A (metabolism)
  • Schizophrenia (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: